WO1998022176A1 - Guiding introducer with openings containing ablation catheter - Google Patents

Guiding introducer with openings containing ablation catheter Download PDF

Info

Publication number
WO1998022176A1
WO1998022176A1 PCT/US1997/021334 US9721334W WO9822176A1 WO 1998022176 A1 WO1998022176 A1 WO 1998022176A1 US 9721334 W US9721334 W US 9721334W WO 9822176 A1 WO9822176 A1 WO 9822176A1
Authority
WO
WIPO (PCT)
Prior art keywords
guiding introducer
openings
ablation
catheter
section
Prior art date
Application number
PCT/US1997/021334
Other languages
French (fr)
Inventor
Michael C. Bednarek
Original Assignee
Daig Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daig Corporation filed Critical Daig Corporation
Publication of WO1998022176A1 publication Critical patent/WO1998022176A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06Body-piercing guide needles or the like
    • A61M25/0662Guide tubes

Definitions

  • This invention relates to a process for the treatment of cardiac arrhythmia using a catheter contained within a guiding introducer containing openings.
  • it relates to a preferred structure for the guiding introducer containing openings which is used with a mapping or ablation catheter for the treatment of cardiac arrhythmia.
  • catheters have been in use for medical procedures for many years. For example, one use is to convey an electrical stimulus to a selected location within the human body. Another use is to monitor and make measurements for diagnostic tests within the human body. Thus, catheters may examine, diagnose and treat while positioned at a specific location within the body which is otherwise inaccessible without more invasive procedures. In use, catheters may be inserted into a vein or artery which is near the body surface. These catheters are then guided to a specific location for examination, diagnosis or treatment by manipulating the catheter through the artery or vein of the human body.
  • Catheters have become increasingly useful in remote and difficult to reach locations within the body.
  • the utilization of these catheters is frequently limited because of the need for precise placement of the electrodes of the catheter at a specific location within the body.
  • the body of a conventional catheter is long and tubular. To provide sufficient control of the movement of the catheter, it is necessary that its structure be somewhat rigid. However, the catheter must not be so rigid as to prevent the bending or curving that is necessary for movement of the catheter through the vein, artery or other body part to arrive at the specified location. Further, the catheter must also not be so rigid as to cause damage to the vasculature while it is being moved within the body. While it is important that the catheter not be so rigid as to cause injury, it is also important that there be sufficient rigidity in the catheter to accommodate torque control, i.e., the ability to transmit a twisting force along the length of the catheter.
  • torque control i.e., the ability to transmit a twisting force along the length of the catheter.
  • Sufficient torque control enables controlled maneuverability of the catheter by the application of a twisting force at the proximal end of the catheter that is transmitted along the catheter to its distal end.
  • the need for greater torque control often conflicts with the need for reduced rigidity to prevent injury to the body vessel.
  • Catheters are used increasingly for medical procedures involving the human heart.
  • a catheter is typically advanced to the heart through a vein or artery and then is positioned at a specified location within the heart.
  • the catheter is inserted in an artery or vein in the leg, neck, upper chest or arm of the patient and threaded, often with the aid of a guidewire or introducer, until the tip of the catheter reaches the desired location in the heart.
  • a new procedure used for treatment of certain cardiac problems in general and cardiac arrhythmia in particular within the last 10 to 15 years is catheter ablation. This procedure has been used to interrupt or modify existing conduction pathways associated with arrhythmia within the heart. The particular area for ablation depends on the type of underlying arrhythmia.
  • One common ablation procedure is the treatment of atrioventricular (AV) nodal reentrant tachycardia. With this problem ablation of the fast or slow AV nodal pathways has become an accepted treatment. See Singer, I., et al., “Catheter Ablation for Arrhythmias" Clinical Manual of Electrophysioloqy. pp. 421-431 (1993) ;
  • ablation catheters for ablating discrete locations within the heart has been disclosed, for example in U.S. Patent Nos. 4,641,649, 5,263,493, 5,231,995, 5,228,442 and 5,281,217.
  • Ablation catheters have also been designed whereby the electrodes are recessed inside the outer surface of the catheter.
  • U.S. Patent No. 5,456,254 discloses an ablation catheter whereby openings for the electrodes are provided in the outer surface of the flexible, elongated catheter assembly.
  • Ablation of a precise location within the heart requires precise placement within the heart of the ablating electrodes of the ablation catheter. Precise positioning is especially difficult within a human heart because of its physiology and because ablation procedures normally occur while the heart is beating.
  • placement of an ablation catheter was accomplished using a combination of electrophysiological guidance and fluoroscopy (placement of the catheter in relation to known features of the heart which are marked by radiopaque diagnostic catheters) .
  • electrophysiological guidance and fluoroscopy placement of the catheter in relation to known features of the heart which are marked by radiopaque diagnostic catheters
  • U.S. Patent No. 5,575,766 discloses a process for the nonsurgical mapping and treatment of atrial arrhythmia using a series of shaped guiding introducers.
  • an ablation catheter is inserted within the lumen of the shaped guiding introducer.
  • the particular shape of the guiding introducer is chosen to direct the ablation catheter to the specific location within the heart for the ablation treatment.
  • the distal tip of the ablation catheter which contains the ablation electrodes, is extended away from the distal tip of the guiding introducer.
  • Each of these guiding introducers are useful in performing ablation procedures at specific locations within the heart.
  • the distal end of the ablation catheter containing its electrode must again be extended away from the distal end of the guiding introducer.
  • the electrodes of the catheter are drawn across the cardiac tissue.
  • Many ablation procedures now require the formation of a linear track or lesion during the ablation procedure.
  • U.S. Patent No. 5,487,385 discloses a system for creating linear lesions in the right atrial chamber of the heart.
  • the system of the , 385 patent utilizes a generally straight, hollow sheath (22) and an ablation catheter (32) contained within the lumen of the sheath.
  • It is a still further object of this invention to disclose a system for linear ablation comprising a guiding introducer containing openings and an ablation catheter, wherein the ablating electrodes of the ablation catheter are retained within the lumen of the guiding introducer containing openings during the ablation procedure.
  • the instant invention includes a process for the nonsurgical mapping and treatment of cardiac arrhythmia using an ablation catheter and a guiding introducer containing openings comprising: introducing into the heart a guiding introducer containing openings wherein the guiding introducer containing openings contains a lumen and a series of openings, introducing into the lumen of the guiding introducer containing openings a catheter for ablating or mapping cardiac tissue containing one or more ablation electrodes, extending the electrodes of the ablation catheter into the distal end of the lumen of the guiding introducer containing openings such that one or more of the electrodes align with at least a portion of one or more of the openings of the guiding introducer containing openings, ablating cardiac tissue through the openings in the guiding introducer containing openings and repeating the ablation procedure as necessary through the openings of the guiding introducer containing openings to form a linear lesion in the heart.
  • the instant invention also discloses a structure for the guiding introducer containing openings comprising a first and second section wherein the first section is a generally hollow, elongated introducer section, wherein the second section contains a plurality of openings, wherein the openings are generally contained within a longitudinal line extending downward through a portion of the second section and wherein the openings are of sufficient size to permit ablation of cardiac tissue by an electrode of the ablation catheter through the openings of the guiding introducer with openings.
  • the instant invention discloses a system for producing linear ablation tracks in cardiac tissue inside the heart comprising a guiding introducer containing openings and an ablation catheter, wherein the structure of the guiding introducer containing openings is as described above.
  • Figure 1 is a side, elevated cutaway view of the guiding introducer containing openings secured to a valve and side port tubing.
  • Figure 2 is a side elevated view of the second section of the guiding introducer containing openings.
  • Figure 3 is a top view of the second section of the guiding introducer containing openings showing the slots of the guiding introducer containing openings.
  • Figure 4 is a top view of the second section of the guiding introducer containing openings rotated 90° clockwise from the position of Figure 3.
  • Figure 5 is a top view of the second section of the guiding introducer containing openings rotated 90° clockwise from the position of Figure 4.
  • Figure 6 is a top view of the second section of the guiding introducer containing openings rotated 90° clockwise from the position of Figure 5.
  • Figure 7 is an end view of the distal tip of the guiding introducer containing openings.
  • Figure 8 is a cutaway view of a portion of the distal end of the guiding introducer containing openings showing the distal tip of the ablation catheter contained within the lumen of the guiding introducer.
  • Figure 9 is a cutaway view of the human heart showing the guiding introducer containing openings placed within the lumen of a shaped sheath in position in the left atrium for performing an ablation procedure.
  • a typical human heart includes a right ventricle, a right atrium, left ventricle and left atrium.
  • the right atrium is in fluid communication with the superior vena cava and the inferior vena cava.
  • the atrioventricular septum separates the right atrium from the right ventricle.
  • the tricuspid valve contained within the atrioventricular septum communicates the right atrium with the right ventricle.
  • On the inner wall of the right atrium where it is connected with the left atrium is a thin walled, recessed portion, the fossa ovalis. Between the fossa ovalis and the tricuspid valve is the opening or ostium for the coronary sinus.
  • the coronary sinus is the large epicardial vein which accommodates most of the venous blood which drains from the myocardium into the right atrium.
  • contraction and relaxation of the heart muscle takes place in an organized fashion as electro-chemical signals pass sequentially through the myocardium from the sinoatrial (SA) node to the atrioventricular (AV) node and then along a well defined route which includes the His-Purkinje system into the left and right ventricles.
  • Initial electric impulses are generated at the SA node and conducted to the AV node.
  • the AV node lies near the ostium of the coronary sinus in the interatrial septum in the right atrium.
  • the His-Purkinje system begins at the AV node and follows along the membranous interatrial septum toward the tricuspid valve through the atrioventricular septum and into the membranous interventricular septum. At about the middle of the interventricular septum, the His-Purkinje system splits into right and left branches which straddle the summit of the muscular part of the interventricular septum.
  • cardiac arrhythmia Sometimes abnormal rhythms occur in the heart which are referred to as cardiac arrhythmia. -lilt is sometimes difficult to isolate a specific pathological cause for these arrhythmias although it is believed that the principle mechanism for many is one or a multitude of reentry circuits.
  • Atrial arrhythmia Another procedure for treatment of atrial arrhythmia involves ablating the His bundle. A permanent pacemaker is then installed, resulting in a regular ventricular beat. See Cox, J.L., et al., "The Surgical Treatment of Atrial Fibrillation," Journal of Thoracic and Cardiovascular Surgery, Vol. 101, No. 4, pp. 570-572 (1991). However, because the atria may continue to fibrillate, normal cardiac hemodynamics are not restored and there is still vulnerability to thromboembolism.
  • a more complex surgical procedure has also been designed to treat atrial arrhythmia. See Cox, J.L., et al., "The Surgical Treatment of Atrial Fibrillation," Journal of Thoracic and Cardiovascular Surgery. Vol 101 pp. 569-83 (1989) .
  • atrial incisions interrupt the conduction routes of those areas in the atria that produce the most common reentrant circuits.
  • the procedure is also designed to direct the sinus impulse from the sinus node to the AV node along a specified route.
  • the entire atrial myocardium (except for the atrial appendages and pulmonary veins) is designed to be electrically active by providing for multiple blind alleys off the main conduction route between the SA node and the AV node, thereby preserving atrial transport function postoperatively. While this procedure has resulted in successful treatments for certain patients, there are significant risks present due to the extensive nature of the surgery.
  • the effectiveness of the "Maze” procedure is dependent upon the destruction of cardiac tissue within the atrium along specific lines or tracks to prevent the formation of reentry circuits while still allowing the atria to contract and permitting the return of normal atrio-ventricular conductivity. It has been discovered that similar success can be achieved without invasive surgery by the use of ablation procedures. These ablation procedures have been effective in the atria of the heart. However, to accomplish these procedures the ablation catheter must be positioned at pre-determined locations to ablate predetermined tracks within the heart, thus forming a natural barrier to the formation of the reentry circuits.
  • the ablation catheters used to perform these ablation procedures produce scar tissue at the ablation site within the heart.
  • the energy necessary to scar or ablate the tissue can be provided by a number of different sources. Originally, direct current was utilized to provide the energy for ablation procedures. Laser, microwave, ultrasound, radio frequency and fulgutronization procedures have also been utilized to perform ablation procedures. However, the preferred source of energy for the ablation procedures is radio frequency energy.
  • fluoroscopes can not easily identify specific features in the heart, thus making accurate placement and utilization of ablation catheters extremely difficult. Accurate placement is especially difficult as the beating heart is in motion, resulting in the catheter moving within the heart as blood is being pumped through the heart.
  • the guiding introducers containing openings of this invention address these problems by positioning the mapping and/or ablation catheter at the precise location necessary for the ablation procedure.
  • the guiding introducer containing openings permits the ablation catheter to ablate cardiac tissue while restrained within the lumen of the guiding introducer containing openings without moving the guiding introducer containing openings itself.
  • the guiding introducer containing openings used for the ablation procedure permits the ablation catheter to move within the guiding introducer containing openings, thus allowing the ablation electrode to create an ablation track without moving the guiding introducer once it is properly positioned.
  • the ablation catheter With the guiding introducer containing openings holding the ablation catheter in a fixed location, the ablation catheter then ablates the cardiac tissue to form the ablation track or lesion. More than one passage over a track generally will be necessary to completely ablate the cardiac tissue. These multiple passes are also made easier by use of the guiding introducer containing openings.
  • conventional guiding introducers such as those disclosed in U.S. Patent No.
  • the distal tip of the ablation catheter must be extended from the distal tip of the guiding introducer to perform the ablation procedure.
  • the ablation electrodes may move from the desired ablation track during the procedure as a result of the movement of the cardiac tissue during the beating of the heart.
  • the movement of blood within the chamber of the heart may also adversely affect the precise placement of the electrodes of the ablation catheter.
  • the guiding introducer containing openings for use with an ablation catheter (10) is preferably divided into two sections (12, 14). See Figure 1.
  • the first section (12) of this guiding introducer containing openings is a conventional, generally elongated, hollow straight introducer section of sufficient length for introduction into the patient and for manipulation from the point of insertion to the specific desired location within the heart.
  • the second section (14) Merged with the distal end of the first section of this guiding introducer containing openings is the second section (14) which forms the portion of the guiding introducer containing the openings.
  • the shape of these openings (16) is not particularly critical. For example, they may be circular openings or extended slots which are longer than they are wide. See Figures 1, 2 and 3.
  • the openings (16) of this second section are preferably aligned in a longitudinal line running to or near the distal tip of the guiding catheter containing openings.
  • a number of individual openings in this section are provided, preferably from about 3 to about 100 individual openings. The number of openings is dependent upon a number of factors, including the size and shape of the individual openings.
  • the overall length of the second section of the guiding introducer containing openings which contains these openings is generally from about 5 to 8 centimeters in length. Extending the openings proximal from the distal tip of the guiding introducer containing openings beyond this distance is not practical because the structure of the guiding introducer containing openings would be weakened substantially.
  • the openings must be sufficiently large to permit an electrode (20) of the ablation catheter (18) which is located against that opening to contact the cardiac tissue with sufficient pressure to create a lesion. See Figure 8. However, the openings must not be so large as to allow the catheter (18) to extend out through any of the openings of the guiding introducer containing openings. While physical contact between the ablating electrode and the cardiac tissue is preferred, adequate lesions may be formed as long as one of the openings in the guiding introducer containing openings is placed between the ablating electrode and the cardiac tissue. In this circumstance, a small gap may exist between the ablating electrode and the cardiac tissue, although that gap will not be wider than the thickness of the wall of the guiding introducer containing openings.
  • the ablating electrode may, in fact, be aligned with more than one opening with a bridge (21) of introducer material present between the two openings. See Figure 8.
  • the ablating electrode may extend across the bridge between two openings and still permit an adequate lesion to be formed in the cardiac tissue.
  • the size of the bridge may be made as small as possible as long as structural stability of the guiding introducer containing openings is retained.
  • the size of the bridge may be larger or smaller depending on the composition of the material of the guiding introducer containing openings.
  • the width of the bridge using conventional introducer material may be 0.5 millimeter or less. Notwithstanding, as long as the ablating electrode is either directly in contact with or directly adjacent to the cardiac tissue through one of the openings, an adequate ablation lesion can be formed.
  • these openings are longer than they are wide to form a slot as shown in Figures 1, 2 and 3.
  • This structure permits a sufficient exposure of the surface of the electrode to the cardiac tissue while at the same time preventing the electrode from passing outside the guiding introducer through its slots. See Figure 8.
  • the length of the slot is from about 3 millimeters to about 10 millimeters. The preferred width of the openings will depend on the size of the ablation electrode of the ablation catheter.
  • the ablation procedures are carried out by the tip electrode (20) of the ablation catheter.
  • the diameter of the tip electrode is approximately equivalent to the outside diameter of the ablation catheter.
  • the diameter of the ablation catheter must be greater than the width of the opening.
  • the widest portion of the opening should be in the range from about 25 to about 90 percent of the diameter of the tip electrode of the ablation catheter and, more preferably, from about 50 to about 90 percent of its diameter.
  • a conventional tip electrode (20) used with an ablation catheter (18) is generally about 4 millimeters in length. While shorter or longer ablating electrodes may be used with the guiding introducer containing openings, in a preferred embodiment the length of this tip electrode should be at least about 4 millimeters or more.
  • This ventilation is preferably produced by means of a series of ventilation apertures (22) within the second section of the guiding introducer containing openings.
  • apertures permit fluids to flow in and out of the guiding introducer containing openings to cool the ablation electrode or electrodes.
  • these apertures are relatively small, circular apertures, although size and shape is not particularly critical.
  • the diameter of these circular apertures (12) is about 0.5 to about 1.5 millimeters.
  • these apertures (22) are also produced in a series extending down the second section of the guiding introducer containing openings. See, for example, Figures 4, 5 and 6.
  • three separate linear series of apertures are provided, each series located about 90° axial from each other and the openings of the guiding introducer containing openings.
  • the distal tip (24) of the guiding introducer containing openings is partially or totally closed to prevent the distal tip from being extended through the distal tip of the guiding introducer containing openings.
  • This structure retains the ablation electrodes of the ablation catheter within the guiding introducer containing openings.
  • a hole (26) is provided in the distal tip (24) as shown in Figures 7 and 8. This hole can be any size less than about 90 percent of the diameter of the tip of the ablation catheter. This hole is preferably about the size of one of the ventilation apertures that are provided axial from the openings.
  • the purpose of the hole is to permit blood located outside the guiding introducer containing openings to be drawn into the lumen of the guiding introducer containing openings as the distal tip of the ablation catheter is pulled away from the distal tip of the guiding introducer containing openings.
  • This hole thus provides better ventilation for the ablating tip electrode (20) by permitting blood to be drawn into the lumen of the guiding introducer containing openings.
  • the outside diameter of the ablation catheter should be approximately the same French size as is the inner diameter of the guiding introducer containing openings. Even when the same French size is utilized however, there is normally a small amount of interior space between the sides of the ablation catheter and the inner wall of the guiding introducer.
  • This space can be used as a conduit to receive injected cooling fluid through the guiding introducer containing openings.
  • a cooling solution is introduced into the guiding introducer containing openings around the ablation catheter during the ablation procedure. This fluid passes down and around the ablation catheter and cools the ablation catheter during the ablation procedure, thus limiting the likelihood of formation of clots or other coagulum from excess heat buildup during an ablation procedure.
  • the guiding introducer containing openings preferably also contains one or a multitude of radiopaque tip markers near its distal tip.
  • a single radiopaque tip marker (28) is located near the distal tip of the guiding introducer containing openings. See Figures 4, 5 and 6.
  • This radiopaque tip marker performs a unique function because of its location.
  • the tip marker is generally square in shape and does not cover more than about 90° of the circumference of the tip of the guiding introducer containing openings, as shown in Figure 5.
  • Placement of the tip marker (28) in a fixed location assists in the precise positioning of the openings of the guiding introducer containing openings under fluoroscopy. This permits the physician to properly position the guiding introducer containing openings such that the openings are placed against the particular cardiac tissue where the ablation procedure is to be performed.
  • the guiding introducer containing openings may be made of any material suitable for use in humans which has a memory or permits distortion from, and substantial return to, the desired shape.
  • the first section of the guiding introducer containing openings is preferably braided to provide greater support for the ablation catheter.
  • the distal portion of the guiding introducer containing openings may also be stiffened by means of a number of well recognized methods, such as braiding as long as the braids, if metal, are isolated from the electrodes. Alternatively, if the distal portion is sufficiently stiff to support its structure, no stiffness means need be used.
  • the internal diameter of the guiding introducer containing openings may vary from about 5 to about 8 "French".
  • Such guiding introducer containing openings can accept ablation catheters from about 5 to about 8 French and appropriate guidewires.
  • modifications in size or shape can be made to the guiding introducer containing openings.
  • the guiding introducer containing openings can be generally straight or it can be formed into a precurved shape.
  • the shape of the guiding introducer containing openings may be such as to permit the openings of the guiding introducer containing openings to rest against the cardiac tissue during the ablation procedure.
  • the choice of possible shapes for the guiding introducer containing openings includes any of the shapes disclosed, for example in U.S. Patent Nos. 5,427,119, 5,497,774, 5,575,766 and 5,564,440.
  • the ablation catheter that is utilized with the guiding introducer containing openings may be a conventional steerable ablation catheter or an ablation catheter which does not have steering capability.
  • a steerable catheter such as a Livewire® ablation catheter produced by Daig Corporation, is utilized.
  • Variations in size and shape of the guiding introducer containing openings are also intended to encompass pediatric uses, although the preferred uses are for adult human hearts. It is well recognized that pediatric uses may require reductions in size of the various sections of the guiding introducer containing openings, in particular the first section, but without any significant modification to the overall shape of the guiding introducer containing openings. In addition, variations in size or shape of the guiding introducer containing openings or ablation catheter are also intended to encompass the specialized situations that sometimes occur in patients with enlarged and rotated hearts.
  • a modified Seldinger technique is normally used for the insertion of the guiding introducer containing openings and ablation catheter into the body.
  • a small skin incision is made at the appropriate location to facilitate the catheter passage.
  • Subcutaneous tissue is then dissected, followed by a puncture of the vessel with an appropriate needle with stylet positioned at a relatively shallow angle.
  • the needle is then partially withdrawn and reinserted at a slightly different angle into the vessel making sure that the needle remains within the vessel.
  • the soft flexible tip of an appropriately sized guidewire is then inserted through, and a short distance beyond, the needle into the vessel. Firmly holding the guidewire in place, the needle is removed.
  • the guidewire is then advanced through the vessel into the appropriate chamber of the heart.
  • the guidewire may be advanced into the right femoral vein through the vena cava into the right atrium.
  • a shaped sheath or pair of such shaped sheaths (30) such as the shaped sheaths distributed by Daig Corporation and disclosed, for example, in U.S. Patent NOS. 5,575,766, 5,427,119, 5,497,774 and 5,564,440, with appropriate dilator is then advanced into the right atrium. While it is preferred that a shaped sheath be used with the guiding introducer containing openings, it is not mandatory.
  • the guiding introducer containing openings may contain its own distinct shape at its distal end which will permit it to be placed in the precise location necessary for the ablation procedure without the necessity of using a shaped sheath.
  • a shaped sheath is used with the guiding introducer containing openings. With the shaped sheath (30) in place, the guiding introducer with openings (10) is advanced within the shaped sheath. It is important that the lumen of the guiding introducer containing openings be filled either with a removable obturator or with the ablation catheter.
  • the ablation catheter (18) and the guiding introducer containing openings (10) generally form an assembly to be advanced together within the shaped sheath (30) into the heart chamber chosen.
  • the electrodes for sensing and ablation of the ablation catheter should rest at or near the distal tip of the guiding introducer containing openings. See Figure 8.
  • the catheter containing electrodes which preferably is a steerable catheter, can steer the assembly to the precise location necessary for the sensing and ablation procedures to occur. See Figure 9. (This Figure shows the guiding introducer containing openings in position for an ablation procedure in the left atrium.)
  • fluoroscopy can be used to assist in the placement of the assembly.
  • the guiding introducer containing openings (10) be anchored in place in the heart by pressing its distal tip (24) against cardiac tissue.
  • the openings (16) of the guiding introducer containing openings are then pressed against the cardiac tissue at the appropriate location for the ablation procedure. See Figure 9.
  • the tip electrode (20) of the ablation catheter (18) is preferably placed adjacent to the distal-most opening (16) of the guiding introducer containing openings (10) .
  • the ablating electrode and one of the openings (16) be perfectly aligned. Adequate lesion formation can occur where the ablating electrode is extended across the bridge (21) between two separate openings. Thus, the actual ablation procedure may occur through one or a pair of adjacent openings. Sufficient energy is then introduced to the ablating tip electrode (20) of the ablation catheter to ablate that particular location.
  • the tip electrode (20) is then partially withdrawn to the next opening in the guiding introducer containing openings (10) where the ablation procedure is repeated.
  • the tip electrode (20) of the ablation catheter (18) can be further withdrawn to create additional lesions until the lesion formed is of adequate length and depth.
  • the tip electrode (20) of the ablation catheter can then be returned to its original position opposite the distal-most opening of the guiding introducer containing openings and the ablation procedure repeated. In practice, it is common for the ablation procedure to be repeated as many as five times to insure formation of an adequate linear track.
  • Sensing electrodes may be utilized during the ablation procedure to sense whether the cardiac arrhythmia has been eliminated. Once it has been determined that an adequate lesion has been formed, the guiding introducer containing openings, the shaped sheath and the ablation catheter are removed.
  • the distal portion of the guiding introducer containing openings can be manipulated to direct the ablating electrode of the mapping and/or ablation catheter to the specific location necessary for the ablation procedure.
  • the guiding introducer containing openings creates a secure platform to permit an adequate ablation procedure to be performed.
  • the structure of the guiding introducer containing openings, the retention of the ablation catheter within the guiding introducer containing openings, and the shape of the shaped sheath also assist in precise placement of the ablation catheter.

Abstract

A guiding introducer (10) containing openings (16) is used with an ablation catheter (18) of cardiac tissue. The introducer comprises a first proximal section (12), generally elongated and hollow, and a second distal section (14), lumened with a plurality of openings (16). The openings (16) have a sufficient size to permit ablation of cardiac tissue through them by an electrode (20) of the ablation catheter (18).

Description

GUIDING INTRODUCER WITH OPENINGS CONTAINING ABLATION CATHETER
This invention relates to a process for the treatment of cardiac arrhythmia using a catheter contained within a guiding introducer containing openings. In addition, it relates to a preferred structure for the guiding introducer containing openings which is used with a mapping or ablation catheter for the treatment of cardiac arrhythmia.
BACKGROUND OF THE INVENTION Introducers and catheters have been in use for medical procedures for many years. For example, one use is to convey an electrical stimulus to a selected location within the human body. Another use is to monitor and make measurements for diagnostic tests within the human body. Thus, catheters may examine, diagnose and treat while positioned at a specific location within the body which is otherwise inaccessible without more invasive procedures. In use, catheters may be inserted into a vein or artery which is near the body surface. These catheters are then guided to a specific location for examination, diagnosis or treatment by manipulating the catheter through the artery or vein of the human body.
Catheters have become increasingly useful in remote and difficult to reach locations within the body. However, the utilization of these catheters is frequently limited because of the need for precise placement of the electrodes of the catheter at a specific location within the body.
Control of the movement of catheters to achieve such precise placement is difficult because of the inherent structure of the catheter. The body of a conventional catheter is long and tubular. To provide sufficient control of the movement of the catheter, it is necessary that its structure be somewhat rigid. However, the catheter must not be so rigid as to prevent the bending or curving that is necessary for movement of the catheter through the vein, artery or other body part to arrive at the specified location. Further, the catheter must also not be so rigid as to cause damage to the vasculature while it is being moved within the body. While it is important that the catheter not be so rigid as to cause injury, it is also important that there be sufficient rigidity in the catheter to accommodate torque control, i.e., the ability to transmit a twisting force along the length of the catheter. Sufficient torque control enables controlled maneuverability of the catheter by the application of a twisting force at the proximal end of the catheter that is transmitted along the catheter to its distal end. The need for greater torque control often conflicts with the need for reduced rigidity to prevent injury to the body vessel.
Catheters are used increasingly for medical procedures involving the human heart. In these procedures a catheter is typically advanced to the heart through a vein or artery and then is positioned at a specified location within the heart. Typically, the catheter is inserted in an artery or vein in the leg, neck, upper chest or arm of the patient and threaded, often with the aid of a guidewire or introducer, until the tip of the catheter reaches the desired location in the heart.
A new procedure used for treatment of certain cardiac problems in general and cardiac arrhythmia in particular within the last 10 to 15 years is catheter ablation. This procedure has been used to interrupt or modify existing conduction pathways associated with arrhythmia within the heart. The particular area for ablation depends on the type of underlying arrhythmia. One common ablation procedure is the treatment of atrioventricular (AV) nodal reentrant tachycardia. With this problem ablation of the fast or slow AV nodal pathways has become an accepted treatment. See Singer, I., et al., "Catheter Ablation for Arrhythmias" Clinical Manual of Electrophysioloqy. pp. 421-431 (1993) ;
Falk, R.H., et al., Atrial Fibrillation Mechanisms in
Management, pp. 359-374 (1992); Horowitz, L.N. ,
Current Management of Arrhythmias. pp. 373-378
(1991); and Martin, D., et al., Atrial Fibrillation. pp. 42-59 (1994) .
The use of ablation catheters for ablating discrete locations within the heart has been disclosed, for example in U.S. Patent Nos. 4,641,649, 5,263,493, 5,231,995, 5,228,442 and 5,281,217. Ablation catheters have also been designed whereby the electrodes are recessed inside the outer surface of the catheter. For example, U.S. Patent No. 5,456,254 discloses an ablation catheter whereby openings for the electrodes are provided in the outer surface of the flexible, elongated catheter assembly.
A similar structure for an ablation catheter is disclosed, for example, in Figure 32 of U.S. Patent
No. 5,499,981. See also U.S. Patent No. 5,425,364.
Ablation of a precise location within the heart requires precise placement within the heart of the ablating electrodes of the ablation catheter. Precise positioning is especially difficult within a human heart because of its physiology and because ablation procedures normally occur while the heart is beating. Conventionally, placement of an ablation catheter was accomplished using a combination of electrophysiological guidance and fluoroscopy (placement of the catheter in relation to known features of the heart which are marked by radiopaque diagnostic catheters) . In order to achieve more precise placement of an ablation catheter, a new ablation procedure involving the use of a shaped, precurved guiding introducers has been developed.
A system comprising a shaped sheath and a steerable catheter for ablation procedures in the heart is disclosed in Figures 20-23 of U.S. Patent No. 5,476,495. In addition, U.S. Patent No. 5,575,766 discloses a process for the nonsurgical mapping and treatment of atrial arrhythmia using a series of shaped guiding introducers. In this process, an ablation catheter is inserted within the lumen of the shaped guiding introducer. The particular shape of the guiding introducer is chosen to direct the ablation catheter to the specific location within the heart for the ablation treatment. However, once the guiding introducer is in place, the distal tip of the ablation catheter, which contains the ablation electrodes, is extended away from the distal tip of the guiding introducer. These electrodes then contact the inner surface of the heart to perform the mapping or ablation procedures. While the shape of the guiding introducer is critical to the successful performance of these procedures, as their shape guides the ablation catheter to the precise location necessary for the ablation procedure, the ablation electrodes still must be extended from the distal tip of the guiding introducer to perform the ablation procedure. The ,766 patent also discloses that treatment of atrial fibrillation requires the formation of linear lesions on the inside surface of the heart. In addition to the guiding introducers disclosed by U.S. Patent No. 5,575,766, other shaped guiding introducers for guiding ablation catheters to particular locations within the heart have been disclosed in U.S. Patent No. 5,427,119, 5,497,774 and 5,564,440. Each of these guiding introducers are useful in performing ablation procedures at specific locations within the heart. However, to perform these ablation procedures, the distal end of the ablation catheter containing its electrode must again be extended away from the distal end of the guiding introducer. To perform the ablation procedure, the electrodes of the catheter are drawn across the cardiac tissue. Many ablation procedures now require the formation of a linear track or lesion during the ablation procedure. U.S. Patent No. 5,487,385 discloses a system for creating linear lesions in the right atrial chamber of the heart. The system of the ,385 patent utilizes a generally straight, hollow sheath (22) and an ablation catheter (32) contained within the lumen of the sheath. To perform the ablation procedure a portion of the distal tip of the ablation catheter extends out from the sheath through an opening (30) . All ablation procedures occur while the ablation catheter is extended outside the body of the sheath. See, for example. Figures 1, 3, 5, 6 and 7.
Even when shaped guiding introducers, such as those disclosed above are used in an ablation procedure, formation of an adequate linear lesion may not be easy because it is difficult to maintain the ablating electrodes of the ablation catheter at the precise location necessary for the ablation procedure for a sufficient period of time. This is especially true because the heart is beating throughout the procedure. Even skilled electrophysiologists now mandate that the location selected for the ablation procedure be ablated multiple times to assure formation of an adequate linear lesion. For all these reasons it is necessary for improvements in medical devices used to direct ablation catheters to the correct location within the heart for mapping and ablation procedures.
Accordingly, it is an object of this invention to disclose a process for the treatment of cardiac arrhythmia by the use of an ablation catheter contained within a guiding introducer containing openings.
It is a still further object of this invention to disclose a process for the formation of ablation tracks or linear lesions within the heart using a guiding introducer containing openings as an element of the treatment of cardiac arrhythmia.
It is a further object of this invention to disclose the structure of a guiding introducer containing openings for electrophysiology procedures for the treatment of cardiac arrhythmia.
It is a still further object of the invention to disclose the structure for a guiding introducer containing openings for use with an ablation catheter for the mapping and ablation of locations within the heart.
It is a still further object of this invention to disclose a guiding introducer containing openings which is utilized with an ablation catheter to form linear ablation tracks or lesions within the heart.
It is a further object of this invention to disclose a guiding introducer containing openings into which an ablation catheter is inserted, whereby the ablation catheter ablates cardiac tissue while the ablation catheter remains within the lumen of the
guiding introducer containing openings.
It is a still further object of this invention to disclose a system for linear ablation comprising a guiding introducer containing openings and an ablation catheter, wherein the ablating electrodes of the ablation catheter are retained within the lumen of the guiding introducer containing openings during the ablation procedure.
It is a still further object of this invention to disclose a process for the nonsurgical treatment of cardiac arrhythmia using an ablation catheter and a guiding introducer containing openings, wherein the ablation catheter is retained within the lumen of the guiding introducer during the treatment and wherein the guiding introducer containing openings is utilized with the ablation catheter to form a linear ablation track or lesion. These and other objects can be obtained by the disclosed process for the treatment of cardiac arrhythmia and the design of the guiding introducer containing openings for use with that process which are disclosed by the instant invention.
SUMMARY OF THE INVENTION The instant invention includes a process for the nonsurgical mapping and treatment of cardiac arrhythmia using an ablation catheter and a guiding introducer containing openings comprising: introducing into the heart a guiding introducer containing openings wherein the guiding introducer containing openings contains a lumen and a series of openings, introducing into the lumen of the guiding introducer containing openings a catheter for ablating or mapping cardiac tissue containing one or more ablation electrodes, extending the electrodes of the ablation catheter into the distal end of the lumen of the guiding introducer containing openings such that one or more of the electrodes align with at least a portion of one or more of the openings of the guiding introducer containing openings, ablating cardiac tissue through the openings in the guiding introducer containing openings and repeating the ablation procedure as necessary through the openings of the guiding introducer containing openings to form a linear lesion in the heart.
The instant invention also discloses a structure for the guiding introducer containing openings comprising a first and second section wherein the first section is a generally hollow, elongated introducer section, wherein the second section contains a plurality of openings, wherein the openings are generally contained within a longitudinal line extending downward through a portion of the second section and wherein the openings are of sufficient size to permit ablation of cardiac tissue by an electrode of the ablation catheter through the openings of the guiding introducer with openings.
In addition, the instant invention discloses a system for producing linear ablation tracks in cardiac tissue inside the heart comprising a guiding introducer containing openings and an ablation catheter, wherein the structure of the guiding introducer containing openings is as described above. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a side, elevated cutaway view of the guiding introducer containing openings secured to a valve and side port tubing. Figure 2 is a side elevated view of the second section of the guiding introducer containing openings.
Figure 3 is a top view of the second section of the guiding introducer containing openings showing the slots of the guiding introducer containing openings.
Figure 4 is a top view of the second section of the guiding introducer containing openings rotated 90° clockwise from the position of Figure 3. Figure 5 is a top view of the second section of the guiding introducer containing openings rotated 90° clockwise from the position of Figure 4.
Figure 6 is a top view of the second section of the guiding introducer containing openings rotated 90° clockwise from the position of Figure 5.
Figure 7 is an end view of the distal tip of the guiding introducer containing openings.
Figure 8 is a cutaway view of a portion of the distal end of the guiding introducer containing openings showing the distal tip of the ablation catheter contained within the lumen of the guiding introducer.
Figure 9 is a cutaway view of the human heart showing the guiding introducer containing openings placed within the lumen of a shaped sheath in position in the left atrium for performing an ablation procedure.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS A typical human heart includes a right ventricle, a right atrium, left ventricle and left atrium. The right atrium is in fluid communication with the superior vena cava and the inferior vena cava. The atrioventricular septum separates the right atrium from the right ventricle. The tricuspid valve contained within the atrioventricular septum communicates the right atrium with the right ventricle. On the inner wall of the right atrium where it is connected with the left atrium is a thin walled, recessed portion, the fossa ovalis. Between the fossa ovalis and the tricuspid valve is the opening or ostium for the coronary sinus. The coronary sinus is the large epicardial vein which accommodates most of the venous blood which drains from the myocardium into the right atrium. In the normal heart, contraction and relaxation of the heart muscle (myocardium) takes place in an organized fashion as electro-chemical signals pass sequentially through the myocardium from the sinoatrial (SA) node to the atrioventricular (AV) node and then along a well defined route which includes the His-Purkinje system into the left and right ventricles. Initial electric impulses are generated at the SA node and conducted to the AV node. The AV node lies near the ostium of the coronary sinus in the interatrial septum in the right atrium. The His-Purkinje system begins at the AV node and follows along the membranous interatrial septum toward the tricuspid valve through the atrioventricular septum and into the membranous interventricular septum. At about the middle of the interventricular septum, the His-Purkinje system splits into right and left branches which straddle the summit of the muscular part of the interventricular septum. Sometimes abnormal rhythms occur in the heart which are referred to as cardiac arrhythmia. -lilt is sometimes difficult to isolate a specific pathological cause for these arrhythmias although it is believed that the principle mechanism for many is one or a multitude of reentry circuits. Efforts to alleviate the effect of these arrhythmia in the past have included significant usage of pharmacological treatments. While pharmacological treatments are sometimes effective, in some circumstances drug therapy has been ineffective and frequently is plagued with side effects such as dizziness, nausea, vision problems and other difficulties.
In the past, surgical procedures have also been utilized in the treatment of some atrial arrhythmia. The goal of these surgical procedures parallels that of the pharmacological treatments, to relieve the subjective symptoms of arrhythmia as well as to normalize hemodynamics . For example, one method suggested for treatment of atrial fibrillation requires isolation of the left atrium from the remainder of the heart by a surgical procedure. See Cox, J.L., et al., "The Surgical Treatment of Atrial Fibrillation," J. Thoracic and Cardiovascular Surgery. Vol. 101, No. 4, p. 570 (1991). The initial incisions followed by the scar tissue left by such surgery effectively isolates the left atrium and, in some cases, provides relief for the patient. Such relief can occur as long as the right atrium maintains adequate sinus rhythm. Various problems associated with this procedure, other than the maintenance of appropriate sinus rhythm, include thromboembolic risks.
Another procedure for treatment of atrial arrhythmia involves ablating the His bundle. A permanent pacemaker is then installed, resulting in a regular ventricular beat. See Cox, J.L., et al., "The Surgical Treatment of Atrial Fibrillation," Journal of Thoracic and Cardiovascular Surgery, Vol. 101, No. 4, pp. 570-572 (1991). However, because the atria may continue to fibrillate, normal cardiac hemodynamics are not restored and there is still vulnerability to thromboembolism.
A more complex surgical procedure, the "Maze" procedure, has also been designed to treat atrial arrhythmia. See Cox, J.L., et al., "The Surgical Treatment of Atrial Fibrillation," Journal of Thoracic and Cardiovascular Surgery. Vol 101 pp. 569-83 (1989) . During this procedure appropriately placed atrial incisions interrupt the conduction routes of those areas in the atria that produce the most common reentrant circuits. The procedure is also designed to direct the sinus impulse from the sinus node to the AV node along a specified route. After the procedure, the entire atrial myocardium (except for the atrial appendages and pulmonary veins) is designed to be electrically active by providing for multiple blind alleys off the main conduction route between the SA node and the AV node, thereby preserving atrial transport function postoperatively. While this procedure has resulted in successful treatments for certain patients, there are significant risks present due to the extensive nature of the surgery.
The effectiveness of the "Maze" procedure is dependent upon the destruction of cardiac tissue within the atrium along specific lines or tracks to prevent the formation of reentry circuits while still allowing the atria to contract and permitting the return of normal atrio-ventricular conductivity. It has been discovered that similar success can be achieved without invasive surgery by the use of ablation procedures. These ablation procedures have been effective in the atria of the heart. However, to accomplish these procedures the ablation catheter must be positioned at pre-determined locations to ablate predetermined tracks within the heart, thus forming a natural barrier to the formation of the reentry circuits. In addition to the necessity of producing ablation tracks or linear lesions in well defined areas of the heart, it is also critical for proper transmural lesion formation that adequate contact pressure be maintained between the ablation catheter electrode and the heart tissue to be ablated. The formation of such linear tracks is disclosed in U.S. Patent No. 5,575,766.
The ablation catheters used to perform these ablation procedures produce scar tissue at the ablation site within the heart. The energy necessary to scar or ablate the tissue can be provided by a number of different sources. Originally, direct current was utilized to provide the energy for ablation procedures. Laser, microwave, ultrasound, radio frequency and fulgutronization procedures have also been utilized to perform ablation procedures. However, the preferred source of energy for the ablation procedures is radio frequency energy.
Mere introduction of an ablation catheter into the heart without precise placement of the ablation electrode at the correct location and consistent pressure on the cardiac tissue will not be sufficient to form the desired ablation tracks or lesions. This precise placement and contact pressure has been produced using specialized precurved guiding introducers to guide the ablation catheter to specific location in the heart and to permit adequate pressure to be placed on the ablation electrode of the ablation catheter to produce an adequately ablated track or lesions in U.S. Patent Nos. 5,427,119, 5,497,774, 5,575,766 and 5,564,440. However, even when using these guiding introducers, production of adequate linear lesions or tracks in the heart may be difficult because these guiding introducers require that the ablating electrodes of the ablation catheter be extended from the distal tip of the guiding introducer. The greater distance that the ablation electrode of the ablation catheter is extended from the distal tip of the guiding introducer, the more likely that problems will occur in the formation of the adequate linear ablation tracks or lesions in cardiac tissue.
Medical practitioners often monitor the introduction of cardiac catheters and their progress through the vascular system by use of fluoroscopes. Unfortunately, fluoroscopes can not easily identify specific features in the heart, thus making accurate placement and utilization of ablation catheters extremely difficult. Accurate placement is especially difficult as the beating heart is in motion, resulting in the catheter moving within the heart as blood is being pumped through the heart.
The guiding introducers containing openings of this invention address these problems by positioning the mapping and/or ablation catheter at the precise location necessary for the ablation procedure. In addition, the guiding introducer containing openings permits the ablation catheter to ablate cardiac tissue while restrained within the lumen of the guiding introducer containing openings without moving the guiding introducer containing openings itself.
The guiding introducer containing openings used for the ablation procedure permits the ablation catheter to move within the guiding introducer containing openings, thus allowing the ablation electrode to create an ablation track without moving the guiding introducer once it is properly positioned. With the guiding introducer containing openings holding the ablation catheter in a fixed location, the ablation catheter then ablates the cardiac tissue to form the ablation track or lesion. More than one passage over a track generally will be necessary to completely ablate the cardiac tissue. These multiple passes are also made easier by use of the guiding introducer containing openings. When conventional guiding introducers such as those disclosed in U.S. Patent No. 5,575,766 are utilized, the distal tip of the ablation catheter must be extended from the distal tip of the guiding introducer to perform the ablation procedure. In this situation, the ablation electrodes may move from the desired ablation track during the procedure as a result of the movement of the cardiac tissue during the beating of the heart. In addition, the movement of blood within the chamber of the heart may also adversely affect the precise placement of the electrodes of the ablation catheter. These problems are alleviated by restraining the ablation catheter within the lumen of the guiding introducer containing openings. The specially designed guiding introducer containing openings is produced from conventional elongated introducers. Although the guiding introducer containing openings is described as having a pair of sections, preferably, it is produced in a conventional introducer production procedure, formed into a single unitary structure.
Additional features of this guiding introducer containing openings other than its unique shape include radiopaque tip markers and vents which will be discussed in more detail later. The guiding introducer containing openings for use with an ablation catheter (10) is preferably divided into two sections (12, 14). See Figure 1. The first section (12) of this guiding introducer containing openings is a conventional, generally elongated, hollow straight introducer section of sufficient length for introduction into the patient and for manipulation from the point of insertion to the specific desired location within the heart. Merged with the distal end of the first section of this guiding introducer containing openings is the second section (14) which forms the portion of the guiding introducer containing the openings. The shape of these openings (16) is not particularly critical. For example, they may be circular openings or extended slots which are longer than they are wide. See Figures 1, 2 and 3.
The openings (16) of this second section are preferably aligned in a longitudinal line running to or near the distal tip of the guiding catheter containing openings. A number of individual openings in this section are provided, preferably from about 3 to about 100 individual openings. The number of openings is dependent upon a number of factors, including the size and shape of the individual openings. The overall length of the second section of the guiding introducer containing openings which contains these openings is generally from about 5 to 8 centimeters in length. Extending the openings proximal from the distal tip of the guiding introducer containing openings beyond this distance is not practical because the structure of the guiding introducer containing openings would be weakened substantially. In addition, ablation tracks or lesions greater in length than about 7 centimeters are not necessary. In a preferred embodiment, the openings must be sufficiently large to permit an electrode (20) of the ablation catheter (18) which is located against that opening to contact the cardiac tissue with sufficient pressure to create a lesion. See Figure 8. However, the openings must not be so large as to allow the catheter (18) to extend out through any of the openings of the guiding introducer containing openings. While physical contact between the ablating electrode and the cardiac tissue is preferred, adequate lesions may be formed as long as one of the openings in the guiding introducer containing openings is placed between the ablating electrode and the cardiac tissue. In this circumstance, a small gap may exist between the ablating electrode and the cardiac tissue, although that gap will not be wider than the thickness of the wall of the guiding introducer containing openings.
In addition, it is not critical that the ablating electrode line up directly with one of the openings. The ablating electrode may, in fact, be aligned with more than one opening with a bridge (21) of introducer material present between the two openings. See Figure 8. The ablating electrode may extend across the bridge between two openings and still permit an adequate lesion to be formed in the cardiac tissue. The size of the bridge may be made as small as possible as long as structural stability of the guiding introducer containing openings is retained. Thus, the size of the bridge may be larger or smaller depending on the composition of the material of the guiding introducer containing openings. In one embodiment, the width of the bridge using conventional introducer material may be 0.5 millimeter or less. Notwithstanding, as long as the ablating electrode is either directly in contact with or directly adjacent to the cardiac tissue through one of the openings, an adequate ablation lesion can be formed.
In a preferred embodiment, these openings are longer than they are wide to form a slot as shown in Figures 1, 2 and 3. This structure permits a sufficient exposure of the surface of the electrode to the cardiac tissue while at the same time preventing the electrode from passing outside the guiding introducer through its slots. See Figure 8. In a preferred embodiment, the length of the slot is from about 3 millimeters to about 10 millimeters. The preferred width of the openings will depend on the size of the ablation electrode of the ablation catheter.
Preferably, the ablation procedures are carried out by the tip electrode (20) of the ablation catheter. In this circumstance, the diameter of the tip electrode is approximately equivalent to the outside diameter of the ablation catheter. The diameter of the ablation catheter must be greater than the width of the opening. Preferably, the widest portion of the opening should be in the range from about 25 to about 90 percent of the diameter of the tip electrode of the ablation catheter and, more preferably, from about 50 to about 90 percent of its diameter.
A conventional tip electrode (20) used with an ablation catheter (18) is generally about 4 millimeters in length. While shorter or longer ablating electrodes may be used with the guiding introducer containing openings, in a preferred embodiment the length of this tip electrode should be at least about 4 millimeters or more. During the ablation procedures where the ablating electrode of the ablation catheter is contained within the guiding introducer containing openings, there may be significant heat build up. To lessen the effect of this heat buildup, it is important that there be ventilation or liquid cooling of the ablating electrode. This ventilation is preferably produced by means of a series of ventilation apertures (22) within the second section of the guiding introducer containing openings. These apertures permit fluids to flow in and out of the guiding introducer containing openings to cool the ablation electrode or electrodes. One embodiment of these apertures is shown, for example, in Figures 2 through 6. Preferably these apertures are relatively small, circular apertures, although size and shape is not particularly critical. In one preferred embodiment, the diameter of these circular apertures (12) is about 0.5 to about 1.5 millimeters. In a preferred embodiment, these apertures (22) are also produced in a series extending down the second section of the guiding introducer containing openings. See, for example, Figures 4, 5 and 6. In a more preferred embodiment, three separate linear series of apertures are provided, each series located about 90° axial from each other and the openings of the guiding introducer containing openings.
In a preferred embodiment the distal tip (24) of the guiding introducer containing openings is partially or totally closed to prevent the distal tip from being extended through the distal tip of the guiding introducer containing openings. This structure retains the ablation electrodes of the ablation catheter within the guiding introducer containing openings. Although the distal tip of the guiding introducer containing openings may be completely closed, in a preferred embodiment, a hole (26) is provided in the distal tip (24) as shown in Figures 7 and 8. This hole can be any size less than about 90 percent of the diameter of the tip of the ablation catheter. This hole is preferably about the size of one of the ventilation apertures that are provided axial from the openings. The purpose of the hole is to permit blood located outside the guiding introducer containing openings to be drawn into the lumen of the guiding introducer containing openings as the distal tip of the ablation catheter is pulled away from the distal tip of the guiding introducer containing openings. This hole thus provides better ventilation for the ablating tip electrode (20) by permitting blood to be drawn into the lumen of the guiding introducer containing openings. The outside diameter of the ablation catheter should be approximately the same French size as is the inner diameter of the guiding introducer containing openings. Even when the same French size is utilized however, there is normally a small amount of interior space between the sides of the ablation catheter and the inner wall of the guiding introducer. This space can be used as a conduit to receive injected cooling fluid through the guiding introducer containing openings. In a preferred embodiment, a cooling solution is introduced into the guiding introducer containing openings around the ablation catheter during the ablation procedure. This fluid passes down and around the ablation catheter and cools the ablation catheter during the ablation procedure, thus limiting the likelihood of formation of clots or other coagulum from excess heat buildup during an ablation procedure.
The guiding introducer containing openings preferably also contains one or a multitude of radiopaque tip markers near its distal tip. In a preferred embodiment a single radiopaque tip marker (28) is located near the distal tip of the guiding introducer containing openings. See Figures 4, 5 and 6. This radiopaque tip marker performs a unique function because of its location. Instead of a conventional ring tip marker which circles the diameter of the guiding introducer containing openings, in a preferred embodiment, the tip marker is generally square in shape and does not cover more than about 90° of the circumference of the tip of the guiding introducer containing openings, as shown in Figure 5. Placement of the tip marker (28) in a fixed location assists in the precise positioning of the openings of the guiding introducer containing openings under fluoroscopy. This permits the physician to properly position the guiding introducer containing openings such that the openings are placed against the particular cardiac tissue where the ablation procedure is to be performed.
The guiding introducer containing openings may be made of any material suitable for use in humans which has a memory or permits distortion from, and substantial return to, the desired shape. In a preferred embodiment the first section of the guiding introducer containing openings is preferably braided to provide greater support for the ablation catheter. The distal portion of the guiding introducer containing openings may also be stiffened by means of a number of well recognized methods, such as braiding as long as the braids, if metal, are isolated from the electrodes. Alternatively, if the distal portion is sufficiently stiff to support its structure, no stiffness means need be used.
For purpose of illustration and not limitation, the internal diameter of the guiding introducer containing openings may vary from about 5 to about 8 "French". Such guiding introducer containing openings can accept ablation catheters from about 5 to about 8 French and appropriate guidewires. Obviously, if larger or smaller ablation catheters are used in conjunction with the guiding introducer containing openings, modifications in size or shape can be made to the guiding introducer containing openings.
The guiding introducer containing openings can be generally straight or it can be formed into a precurved shape. The shape of the guiding introducer containing openings may be such as to permit the openings of the guiding introducer containing openings to rest against the cardiac tissue during the ablation procedure. The choice of possible shapes for the guiding introducer containing openings includes any of the shapes disclosed, for example in U.S. Patent Nos. 5,427,119, 5,497,774, 5,575,766 and 5,564,440.
The ablation catheter that is utilized with the guiding introducer containing openings may be a conventional steerable ablation catheter or an ablation catheter which does not have steering capability. In a preferred embodiment, a steerable catheter, such as a Livewire® ablation catheter produced by Daig Corporation, is utilized.
Variations in size and shape of the guiding introducer containing openings are also intended to encompass pediatric uses, although the preferred uses are for adult human hearts. It is well recognized that pediatric uses may require reductions in size of the various sections of the guiding introducer containing openings, in particular the first section, but without any significant modification to the overall shape of the guiding introducer containing openings. In addition, variations in size or shape of the guiding introducer containing openings or ablation catheter are also intended to encompass the specialized situations that sometimes occur in patients with enlarged and rotated hearts.
In operation, a modified Seldinger technique is normally used for the insertion of the guiding introducer containing openings and ablation catheter into the body. Using this procedure, a small skin incision is made at the appropriate location to facilitate the catheter passage. Subcutaneous tissue is then dissected, followed by a puncture of the vessel with an appropriate needle with stylet positioned at a relatively shallow angle. The needle is then partially withdrawn and reinserted at a slightly different angle into the vessel making sure that the needle remains within the vessel. The soft flexible tip of an appropriately sized guidewire is then inserted through, and a short distance beyond, the needle into the vessel. Firmly holding the guidewire in place, the needle is removed. The guidewire is then advanced through the vessel into the appropriate chamber of the heart. For example, if the ablation procedure is to occur in the right atrium, the guidewire may be advanced into the right femoral vein through the vena cava into the right atrium. A shaped sheath or pair of such shaped sheaths (30) , such as the shaped sheaths distributed by Daig Corporation and disclosed, for example, in U.S. Patent NOS. 5,575,766, 5,427,119, 5,497,774 and 5,564,440, with appropriate dilator is then advanced into the right atrium. While it is preferred that a shaped sheath be used with the guiding introducer containing openings, it is not mandatory. For example, the guiding introducer containing openings may contain its own distinct shape at its distal end which will permit it to be placed in the precise location necessary for the ablation procedure without the necessity of using a shaped sheath. However, in a preferred embodiment, a shaped sheath is used with the guiding introducer containing openings. With the shaped sheath (30) in place, the guiding introducer with openings (10) is advanced within the shaped sheath. It is important that the lumen of the guiding introducer containing openings be filled either with a removable obturator or with the ablation catheter. Preferably, the ablation catheter (18) and the guiding introducer containing openings (10) generally form an assembly to be advanced together within the shaped sheath (30) into the heart chamber chosen. The electrodes for sensing and ablation of the ablation catheter should rest at or near the distal tip of the guiding introducer containing openings. See Figure 8. If necessary, the catheter containing electrodes which preferably is a steerable catheter, can steer the assembly to the precise location necessary for the sensing and ablation procedures to occur. See Figure 9. (This Figure shows the guiding introducer containing openings in position for an ablation procedure in the left atrium.) In addition, fluoroscopy can be used to assist in the placement of the assembly. In order to perform the ablation procedure, it is preferable that the guiding introducer containing openings (10) be anchored in place in the heart by pressing its distal tip (24) against cardiac tissue. The openings (16) of the guiding introducer containing openings are then pressed against the cardiac tissue at the appropriate location for the ablation procedure. See Figure 9.
In order to perform the ablation procedure, the tip electrode (20) of the ablation catheter (18) is preferably placed adjacent to the distal-most opening (16) of the guiding introducer containing openings (10) . As stated above, it is not critical that the ablating electrode and one of the openings (16) be perfectly aligned. Adequate lesion formation can occur where the ablating electrode is extended across the bridge (21) between two separate openings. Thus, the actual ablation procedure may occur through one or a pair of adjacent openings. Sufficient energy is then introduced to the ablating tip electrode (20) of the ablation catheter to ablate that particular location. In order to form a linear ablation lesion, the tip electrode (20) is then partially withdrawn to the next opening in the guiding introducer containing openings (10) where the ablation procedure is repeated. Depending upon the length of the lesion that is required, the tip electrode (20) of the ablation catheter (18) can be further withdrawn to create additional lesions until the lesion formed is of adequate length and depth. If preferred, the tip electrode (20) of the ablation catheter can then be returned to its original position opposite the distal-most opening of the guiding introducer containing openings and the ablation procedure repeated. In practice, it is common for the ablation procedure to be repeated as many as five times to insure formation of an adequate linear track. Sensing electrodes may be utilized during the ablation procedure to sense whether the cardiac arrhythmia has been eliminated. Once it has been determined that an adequate lesion has been formed, the guiding introducer containing openings, the shaped sheath and the ablation catheter are removed.
By use of the ablation catheter (18) with the guiding introducer containing openings (10) in coordination with fluoroscopic viewing, the distal portion of the guiding introducer containing openings can be manipulated to direct the ablating electrode of the mapping and/or ablation catheter to the specific location necessary for the ablation procedure. In addition, by providing sufficient rigidity and support, as the guiding introducer containing openings is held in place against the cardiac tissue, the guiding introducer containing openings creates a secure platform to permit an adequate ablation procedure to be performed. The structure of the guiding introducer containing openings, the retention of the ablation catheter within the guiding introducer containing openings, and the shape of the shaped sheath also assist in precise placement of the ablation catheter. This precise placement of the ablation catheter tip in the correct location is important as there will be no dilution of energy delivered due to the unfocused energy being dissipated over the entire cardiac chamber and lost in the circulating blood by a constantly moving tip of the ablating catheter. This process permits a significantly reduced usage of energy during the ablation procedure. Further, the time used to perform the ablation procedure is significantly reduced over procedures where no guiding introducer containing openings is used. In addition, by this ablation procedure the same types of destruction of the discrete tracks can be achieved as has been accomplished, for example, in surgical applications and other ablation procedures. It will be apparent from the foregoing that while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that this invention be limited except as by the appended claims. Although the present invention has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention.

Claims

WHAT IS CLAIMED IS:
1. A guiding introducer containing openings for use with an ablation catheter for ablation of cardiac tissue comprising a first proximal and second distal section, wherein the first proximal section is a generally elongated, hollow section, wherein the second distal section is a lumened section containing a plurality of openings and wherein the openings in the second distal section are of sufficient size to permit ablation of cardiac tissue through the openings by an electrode of the ablation catheter.
2. The guiding introducer containing openings of Claim 1, wherein the introducer contains an inner diameter and wherein the openings contain a width across the opening, which width extends around the circumference of the guiding introducer, and a length across the opening extending longitudinally down the second distal section of the guiding introducer.
3. The guiding introducer of Claim 2 , wherein the width of the openings is from about 25 to about 90 percent of the inner diameter of the guiding introducer.
4. The guiding introducer of Claim 2 , wherein the length of the openings is from about 25 to about 90 percent of the inner diameter of the guiding introducer.
5. The guiding introducer of Claim 2 , wherein the second section contains a distal tip, wherein the distal tip contains a hole less than about 90 percent of the inner diameter of the guiding introducer.
6. The guiding introducer of Claim 1 wherein the openings are contained within a linear line extending longitudinally along the second section.
7. The guiding introducer of Claim 1, wherein the guiding introducer contains a series of apertures located from about 45 to about 180 degrees axial from the openings.
8. The guiding introducer of Claim 1, wherein the second section contains a tip marker which extends partially around the circumference of the guiding introducer.
9. The guiding introducer of Claim 1, wherein the second section of the guiding introducer is steerable by a steerable catheter.
10. A system for linear ablation comprising a guiding introducer containing openings and an ablation catheter with electrodes, wherein the guiding introducer comprises a first proximal and second distal section, wherein the first proximal section is generally an elongated, hollow section, wherein the second distal section comprises a lumened section containing a plurality of openings and wherein the openings are of sufficient size to permit ablation of cardiac tissue through the openings by the electrodes of the ablation catheter.
PCT/US1997/021334 1996-11-18 1997-11-18 Guiding introducer with openings containing ablation catheter WO1998022176A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/751,303 1996-11-18
US08/751,303 US5785706A (en) 1996-11-18 1996-11-18 Nonsurgical mapping and treatment of cardiac arrhythmia using a catheter contained within a guiding introducer containing openings

Publications (1)

Publication Number Publication Date
WO1998022176A1 true WO1998022176A1 (en) 1998-05-28

Family

ID=25021400

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/021334 WO1998022176A1 (en) 1996-11-18 1997-11-18 Guiding introducer with openings containing ablation catheter

Country Status (2)

Country Link
US (1) US5785706A (en)
WO (1) WO1998022176A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1916956A2 (en) * 2005-08-22 2008-05-07 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation
US8864758B2 (en) 2003-01-21 2014-10-21 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter design that facilitates positioning at tissue to be diagnosed or treated
WO2017178077A1 (en) * 2016-04-15 2017-10-19 Glenn Van Langenhove Improved method and device for ablation
WO2018193283A1 (en) 2017-04-18 2018-10-25 Glenn Van Langenhove Improved device for ablation

Families Citing this family (177)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161543A (en) 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
US5814029A (en) * 1994-11-03 1998-09-29 Daig Corporation Guiding introducer system for use in ablation and mapping procedures in the left ventricle
US5897553A (en) 1995-11-02 1999-04-27 Medtronic, Inc. Ball point fluid-assisted electrocautery device
US6409722B1 (en) 1998-07-07 2002-06-25 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6235021B1 (en) * 1995-05-01 2001-05-22 Scimed Life Systems, Inc. Ablation sheath
NL1003024C2 (en) * 1996-05-03 1997-11-06 Tjong Hauw Sie Stimulus conduction blocking instrument.
US6311692B1 (en) * 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US6840936B2 (en) * 1996-10-22 2005-01-11 Epicor Medical, Inc. Methods and devices for ablation
US6719755B2 (en) * 1996-10-22 2004-04-13 Epicor Medical, Inc. Methods and devices for ablation
US7052493B2 (en) 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US6805128B1 (en) 1996-10-22 2004-10-19 Epicor Medical, Inc. Apparatus and method for ablating tissue
US20040260278A1 (en) * 1996-10-22 2004-12-23 Anderson Scott C. Apparatus and method for ablating tissue
ES2238759T3 (en) * 1997-06-05 2005-09-01 Adiana, Inc. APPARATUS FOR THE OCLUSION OF THE UTERINE TRUMPS.
US5938660A (en) * 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6251109B1 (en) 1997-06-27 2001-06-26 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6096037A (en) 1997-07-29 2000-08-01 Medtronic, Inc. Tissue sealing electrosurgery device and methods of sealing tissue
US6080151A (en) * 1997-07-21 2000-06-27 Daig Corporation Ablation catheter
US5951475A (en) * 1997-09-25 1999-09-14 International Business Machines Corporation Methods and apparatus for registering CT-scan data to multiple fluoroscopic images
US6464699B1 (en) * 1997-10-10 2002-10-15 Scimed Life Systems, Inc. Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same
US8709007B2 (en) * 1997-10-15 2014-04-29 St. Jude Medical, Atrial Fibrillation Division, Inc. Devices and methods for ablating cardiac tissue
US6120500A (en) * 1997-11-12 2000-09-19 Daig Corporation Rail catheter ablation and mapping system
US6200315B1 (en) * 1997-12-18 2001-03-13 Medtronic, Inc. Left atrium ablation catheter
US6134478A (en) * 1998-06-05 2000-10-17 Intermedics Inc. Method for making cardiac leads with zone insulated electrodes
US6240320B1 (en) 1998-06-05 2001-05-29 Intermedics Inc. Cardiac lead with zone insulated electrodes
US6706039B2 (en) 1998-07-07 2004-03-16 Medtronic, Inc. Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US6315777B1 (en) * 1998-07-07 2001-11-13 Medtronic, Inc. Method and apparatus for creating a virtual electrode used for the ablation of tissue
US6537248B2 (en) 1998-07-07 2003-03-25 Medtronic, Inc. Helical needle apparatus for creating a virtual electrode used for the ablation of tissue
US8308719B2 (en) 1998-09-21 2012-11-13 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and method for ablating tissue
US6190382B1 (en) * 1998-12-14 2001-02-20 Medwaves, Inc. Radio-frequency based catheter system for ablation of body tissues
US20070066972A1 (en) * 2001-11-29 2007-03-22 Medwaves, Inc. Ablation catheter apparatus with one or more electrodes
US6309384B1 (en) 1999-02-01 2001-10-30 Adiana, Inc. Method and apparatus for tubal occlusion
US8702727B1 (en) 1999-02-01 2014-04-22 Hologic, Inc. Delivery catheter with implant ejection mechanism
EP1207788A4 (en) 1999-07-19 2009-12-09 St Jude Medical Atrial Fibrill Apparatus and method for ablating tissue
US20040147912A1 (en) * 1999-08-25 2004-07-29 Cardiofocus, Inc. Surgical ablation system with sliding ablation device
US8221402B2 (en) 2000-01-19 2012-07-17 Medtronic, Inc. Method for guiding a medical device
US7706882B2 (en) 2000-01-19 2010-04-27 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area
US6558385B1 (en) 2000-09-22 2003-05-06 Tissuelink Medical, Inc. Fluid-assisted medical device
ES2643763T3 (en) 2000-03-06 2017-11-24 Salient Surgical Technologies, Inc. Fluid supply system and controller for electrosurgical devices
US8083736B2 (en) 2000-03-06 2011-12-27 Salient Surgical Technologies, Inc. Fluid-assisted medical devices, systems and methods
US8048070B2 (en) 2000-03-06 2011-11-01 Salient Surgical Technologies, Inc. Fluid-assisted medical devices, systems and methods
US7811282B2 (en) * 2000-03-06 2010-10-12 Salient Surgical Technologies, Inc. Fluid-assisted electrosurgical devices, electrosurgical unit with pump and methods of use thereof
US6689131B2 (en) 2001-03-08 2004-02-10 Tissuelink Medical, Inc. Electrosurgical device having a tissue reduction sensor
US6478776B1 (en) 2000-04-05 2002-11-12 Biocardia, Inc. Implant delivery catheter system and methods for its use
US6638268B2 (en) 2000-04-07 2003-10-28 Imran K. Niazi Catheter to cannulate the coronary sinus
US6514250B1 (en) 2000-04-27 2003-02-04 Medtronic, Inc. Suction stabilized epicardial ablation devices
US6546935B2 (en) 2000-04-27 2003-04-15 Atricure, Inc. Method for transmural ablation
EP1278471B1 (en) 2000-04-27 2005-06-15 Medtronic, Inc. Vibration sensitive ablation apparatus
US6942661B2 (en) 2000-08-30 2005-09-13 Boston Scientific Scimed, Inc. Fluid cooled apparatus for supporting diagnostic and therapeutic elements in contact with tissue
US6926669B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Heart wall ablation/mapping catheter and method
US20020087151A1 (en) * 2000-12-29 2002-07-04 Afx, Inc. Tissue ablation apparatus with a sliding ablation instrument and method
US20040138621A1 (en) 2003-01-14 2004-07-15 Jahns Scott E. Devices and methods for interstitial injection of biologic agents into tissue
US7740623B2 (en) 2001-01-13 2010-06-22 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US7959626B2 (en) 2001-04-26 2011-06-14 Medtronic, Inc. Transmural ablation systems and methods
US6807968B2 (en) 2001-04-26 2004-10-26 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
US6663627B2 (en) 2001-04-26 2003-12-16 Medtronic, Inc. Ablation system and method of use
US6699240B2 (en) 2001-04-26 2004-03-02 Medtronic, Inc. Method and apparatus for tissue ablation
US6939350B2 (en) 2001-10-22 2005-09-06 Boston Scientific Scimed, Inc. Apparatus for supporting diagnostic and therapeutic elements in contact with tissue including electrode cooling device
JP2005511135A (en) * 2001-11-29 2005-04-28 メッドウェイブズ、インコーポレイテッド High frequency based catheter system with improved deflection and steering mechanisms
US20090281541A1 (en) * 2008-05-09 2009-11-12 Estech, Inc. Conduction block systems and methods
US7967816B2 (en) 2002-01-25 2011-06-28 Medtronic, Inc. Fluid-assisted electrosurgical instrument with shapeable electrode
US20070293855A1 (en) * 2002-02-15 2007-12-20 Sliwa John W Jr Methods and devices for ablation
US20030191453A1 (en) * 2002-04-03 2003-10-09 Velez Omar E. Catheter assembly
US6932813B2 (en) * 2002-05-03 2005-08-23 Scimed Life Systems, Inc. Ablation systems including insulated energy transmitting elements
US7118566B2 (en) 2002-05-16 2006-10-10 Medtronic, Inc. Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue
US7294143B2 (en) 2002-05-16 2007-11-13 Medtronic, Inc. Device and method for ablation of cardiac tissue
US7572257B2 (en) 2002-06-14 2009-08-11 Ncontact Surgical, Inc. Vacuum coagulation and dissection probes
US8235990B2 (en) 2002-06-14 2012-08-07 Ncontact Surgical, Inc. Vacuum coagulation probes
US7063698B2 (en) * 2002-06-14 2006-06-20 Ncontact Surgical, Inc. Vacuum coagulation probes
US9439714B2 (en) * 2003-04-29 2016-09-13 Atricure, Inc. Vacuum coagulation probes
US6893442B2 (en) 2002-06-14 2005-05-17 Ablatrics, Inc. Vacuum coagulation probe for atrial fibrillation treatment
EP1572020A4 (en) 2002-10-29 2006-05-03 Tissuelink Medical Inc Fluid-assisted electrosurgical scissors and methods
US7083620B2 (en) 2002-10-30 2006-08-01 Medtronic, Inc. Electrosurgical hemostat
US6695609B1 (en) * 2002-12-06 2004-02-24 John Zink Company, Llc Compact low NOx gas burner apparatus and methods
US6984232B2 (en) * 2003-01-17 2006-01-10 St. Jude Medical, Daig Division, Inc. Ablation catheter assembly having a virtual electrode comprising portholes
US6960207B2 (en) * 2003-01-21 2005-11-01 St Jude Medical, Daig Division, Inc. Ablation catheter having a virtual electrode comprising portholes and a porous conductor
US7819866B2 (en) 2003-01-21 2010-10-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter and electrode
US7229450B1 (en) 2003-02-11 2007-06-12 Pacesetter, Inc. Kink resistant introducer with mapping capabilities
US20040186467A1 (en) * 2003-03-21 2004-09-23 Swanson David K. Apparatus for maintaining contact between diagnostic and therapeutic elements and tissue and systems including the same
US7288092B2 (en) * 2003-04-23 2007-10-30 Atricure, Inc. Method and apparatus for ablating cardiac tissue with guide facility
US7497857B2 (en) 2003-04-29 2009-03-03 Medtronic, Inc. Endocardial dispersive electrode for use with a monopolar RF ablation pen
US7056314B1 (en) 2003-05-30 2006-06-06 Pacesetter, Inc. Steerable obturator
US20040260271A1 (en) * 2003-06-18 2004-12-23 Huyser Richard F. Extended fenestration catheter with internal coil and method of making the same
US7101362B2 (en) 2003-07-02 2006-09-05 St. Jude Medical, Atrial Fibrillation Division, Inc. Steerable and shapable catheter employing fluid force
US7789877B2 (en) * 2003-07-02 2010-09-07 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter electrode arrangement
US7235070B2 (en) 2003-07-02 2007-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation fluid manifold for ablation catheter
US8147486B2 (en) * 2003-09-22 2012-04-03 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device with flexible printed circuit
US7229437B2 (en) * 2003-09-22 2007-06-12 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device having integral traces and formed electrodes
US7234225B2 (en) * 2003-09-22 2007-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Method for manufacturing medical device having embedded traces and formed electrodes
CA2771129C (en) * 2003-10-31 2015-09-29 Trudell Medical International System and method for manipulating a catheter for delivering a substance to a body cavity
US8052676B2 (en) * 2003-12-02 2011-11-08 Boston Scientific Scimed, Inc. Surgical methods and apparatus for stimulating tissue
US7608072B2 (en) 2003-12-02 2009-10-27 Boston Scientific Scimed, Inc. Surgical methods and apparatus for maintaining contact between tissue and electrophysiology elements and confirming whether a therapeutic lesion has been formed
US20050267467A1 (en) * 2004-01-16 2005-12-01 Saurav Paul Bipolar conforming electrode catheter and methods for ablation
US7727232B1 (en) 2004-02-04 2010-06-01 Salient Surgical Technologies, Inc. Fluid-assisted medical devices and methods
US7371233B2 (en) * 2004-02-19 2008-05-13 Boston Scientific Scimed, Inc. Cooled probes and apparatus for maintaining contact between cooled probes and tissue
US20050187545A1 (en) * 2004-02-20 2005-08-25 Hooven Michael D. Magnetic catheter ablation device and method
US8333764B2 (en) 2004-05-12 2012-12-18 Medtronic, Inc. Device and method for determining tissue thickness and creating cardiac ablation lesions
US20060009756A1 (en) 2004-05-14 2006-01-12 Francischelli David E Method and devices for treating atrial fibrillation by mass ablation
US7276064B2 (en) 2004-05-27 2007-10-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Side-port sheath for catheter placement and translation
WO2005120374A1 (en) 2004-06-02 2005-12-22 Medtronic, Inc. Compound bipolar ablation device and method
WO2005120375A2 (en) 2004-06-02 2005-12-22 Medtronic, Inc. Loop ablation apparatus and method
WO2005120376A2 (en) 2004-06-02 2005-12-22 Medtronic, Inc. Ablation device with jaws
ATE516762T1 (en) 2004-06-02 2011-08-15 Medtronic Inc ABLATION AND STAPLE INSTRUMENT
US8926635B2 (en) * 2004-06-18 2015-01-06 Medtronic, Inc. Methods and devices for occlusion of an atrial appendage
US8663245B2 (en) 2004-06-18 2014-03-04 Medtronic, Inc. Device for occlusion of a left atrial appendage
US8409219B2 (en) 2004-06-18 2013-04-02 Medtronic, Inc. Method and system for placement of electrical lead inside heart
KR101202369B1 (en) * 2004-10-29 2012-11-16 가부시키가이샤 가네카 메딕스 Medical wire
US20060149121A1 (en) * 2005-01-03 2006-07-06 Hughett James D Sr Instrument guide and method for use
US8029528B2 (en) * 2005-01-03 2011-10-04 Atricure, Inc. Instrument guide and method for use
US8932208B2 (en) 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
US8016822B2 (en) * 2005-05-28 2011-09-13 Boston Scientific Scimed, Inc. Fluid injecting devices and methods and apparatus for maintaining contact between fluid injecting devices and tissue
US7419486B2 (en) * 2005-06-15 2008-09-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Treatment and diagnostic catheters with hydrogel electrodes
US7776034B2 (en) * 2005-06-15 2010-08-17 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter with adjustable virtual electrode
US7819868B2 (en) 2005-06-21 2010-10-26 St. Jude Medical, Atrial Fibrilation Division, Inc. Ablation catheter with fluid distribution structures
US7879030B2 (en) 2005-07-27 2011-02-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, virtual-electrode catheter with at least one surface electrode and method for ablation
US9808280B2 (en) * 2005-10-12 2017-11-07 Atricure, Inc. Diaphragm entry for posterior surgical access
WO2007046860A2 (en) 2005-10-12 2007-04-26 Ncontact Surgical, Inc. Diaphragm entry for posterior surgical access
US8721597B2 (en) * 2006-11-09 2014-05-13 Ncontact Surgical, Inc. Diaphragm entry for posterior surgical access
US8211011B2 (en) 2006-11-09 2012-07-03 Ncontact Surgical, Inc. Diaphragm entry for posterior surgical access
EP1998683B1 (en) * 2006-03-09 2016-09-07 Cybersonics, Inc. Catheters
US20080039746A1 (en) 2006-05-25 2008-02-14 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US20070299403A1 (en) * 2006-06-23 2007-12-27 Crowe John E Directional introducer
US7699845B2 (en) * 2006-06-23 2010-04-20 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation device and method with connector
US7774039B2 (en) 2006-09-05 2010-08-10 Boston Scientific Scimed, Inc. Multi-bend steerable mapping catheter
JP5054116B2 (en) * 2006-11-09 2012-10-24 エヌコンタクト サージカル, インコーポレイテッド Vacuum coagulation probe
US20090036840A1 (en) * 2006-11-22 2009-02-05 Cytyc Corporation Atraumatic ball tip and side wall opening
US20100063360A1 (en) * 2006-11-28 2010-03-11 Adiana, Inc. Side-arm Port Introducer
US20080161799A1 (en) * 2006-12-29 2008-07-03 Todd Stangenes Position independent catheter
CA2676119C (en) 2007-01-29 2021-01-19 Simon Fraser University Transvascular nerve stimulation apparatus and methods
US9314298B2 (en) * 2007-04-17 2016-04-19 St. Jude Medical, Atrial Fibrillation Divisions, Inc. Vacuum-stabilized ablation system
US20090082762A1 (en) * 2007-09-20 2009-03-26 Ormsby Theodore C Radio frequency energy transmission device for the ablation of biological tissues
EP2209517A4 (en) 2007-10-05 2011-03-30 Maquet Cardiovascular Llc Devices and methods for minimally-invasive surgical procedures
US20090125023A1 (en) * 2007-11-13 2009-05-14 Cytyc Corporation Electrosurgical Instrument
EP2227174B1 (en) 2007-12-28 2019-05-01 Salient Surgical Technologies, Inc. Fluid-assisted electrosurgical device
US8858528B2 (en) * 2008-04-23 2014-10-14 Ncontact Surgical, Inc. Articulating cannula access device
US8821488B2 (en) 2008-05-13 2014-09-02 Medtronic, Inc. Tissue lesion evaluation
US8133222B2 (en) * 2008-05-28 2012-03-13 Medwaves, Inc. Tissue ablation apparatus and method using ultrasonic imaging
US8267951B2 (en) * 2008-06-12 2012-09-18 Ncontact Surgical, Inc. Dissecting cannula and methods of use thereof
US8679106B2 (en) * 2008-07-01 2014-03-25 Medwaves, Inc. Angioplasty and tissue ablation apparatus and method
US8864728B2 (en) * 2008-12-31 2014-10-21 Kci Licensing, Inc. Multi-conduit manifolds, systems, and methods for applying reduced pressure to a subcutaneous tissue site
US9320565B2 (en) * 2008-12-31 2016-04-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation devices, systems and method for measuring cooling effect of fluid flow
AU2009333031B2 (en) * 2008-12-31 2015-09-10 Solventum Intellectual Properties Company Sleeves, manifolds, systems, and methods for applying reduced pressure to a subcutaneous tissue site
US9254168B2 (en) 2009-02-02 2016-02-09 Medtronic Advanced Energy Llc Electro-thermotherapy of tissue using penetrating microelectrode array
US8725228B2 (en) * 2009-02-20 2014-05-13 Boston Scientific Scimed, Inc. Steerable catheter having intermediate stiffness transition zone
JP5592409B2 (en) 2009-02-23 2014-09-17 サリエント・サージカル・テクノロジーズ・インコーポレーテッド Fluid-assisted electrosurgical device and method of use thereof
IN2012DN01917A (en) 2009-09-08 2015-07-24 Salient Surgical Tech Inc
US8231619B2 (en) * 2010-01-22 2012-07-31 Cytyc Corporation Sterilization device and method
WO2011112991A1 (en) 2010-03-11 2011-09-15 Salient Surgical Technologies, Inc. Bipolar electrosurgical cutter with position insensitive return electrode contact
US8550086B2 (en) 2010-05-04 2013-10-08 Hologic, Inc. Radiopaque implant
US20110295249A1 (en) * 2010-05-28 2011-12-01 Salient Surgical Technologies, Inc. Fluid-Assisted Electrosurgical Devices, and Methods of Manufacture Thereof
US9138289B2 (en) 2010-06-28 2015-09-22 Medtronic Advanced Energy Llc Electrode sheath for electrosurgical device
US8906012B2 (en) 2010-06-30 2014-12-09 Medtronic Advanced Energy Llc Electrosurgical devices with wire electrode
US8920417B2 (en) 2010-06-30 2014-12-30 Medtronic Advanced Energy Llc Electrosurgical devices and methods of use thereof
US9023040B2 (en) 2010-10-26 2015-05-05 Medtronic Advanced Energy Llc Electrosurgical cutting devices
US9427281B2 (en) 2011-03-11 2016-08-30 Medtronic Advanced Energy Llc Bronchoscope-compatible catheter provided with electrosurgical device
WO2012145077A1 (en) 2011-04-22 2012-10-26 Topera, Inc. Method for detection of cardiac rhythm disorders using basket style cardiac mapping catheter
US9750565B2 (en) 2011-09-30 2017-09-05 Medtronic Advanced Energy Llc Electrosurgical balloons
US8870864B2 (en) 2011-10-28 2014-10-28 Medtronic Advanced Energy Llc Single instrument electrosurgery apparatus and its method of use
US9125573B2 (en) * 2011-12-29 2015-09-08 St. Jude Medical, Atrial Fibrillation Division, Inc. Electrically transparent introducer sheath
CN107126622A (en) 2012-03-05 2017-09-05 西蒙·弗雷瑟大学 neural stimulation system
BR112014032002A2 (en) 2012-06-21 2017-06-27 Univ Fraser Simon transvascular diaphragm stimulation systems and methods of use
EP2679275B1 (en) * 2012-06-28 2014-05-14 Peter Osypka Stiftung Epicardial mapping electrode
US9072864B2 (en) * 2012-11-28 2015-07-07 Ad-Tech Medical Instrument Corporation Catheter with depth electrode for dual-purpose use
AU2014351473B2 (en) 2013-11-22 2019-11-07 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
EP3824949B1 (en) 2014-01-21 2023-12-20 Lungpacer Medical Inc. Systems for optimization of multi-electrode nerve pacing
US10194978B2 (en) * 2014-06-13 2019-02-05 Medtronic Cryocath Lp Supporting catheter for use for phrenic nerve pacing
US9974599B2 (en) 2014-08-15 2018-05-22 Medtronic Ps Medical, Inc. Multipurpose electrosurgical device
US11389227B2 (en) 2015-08-20 2022-07-19 Medtronic Advanced Energy Llc Electrosurgical device with multivariate control
US11051875B2 (en) 2015-08-24 2021-07-06 Medtronic Advanced Energy Llc Multipurpose electrosurgical device
US10716612B2 (en) 2015-12-18 2020-07-21 Medtronic Advanced Energy Llc Electrosurgical device with multiple monopolar electrode assembly
KR20190062419A (en) 2016-10-04 2019-06-05 아벤트, 인크. The cooled RF probe
US10293164B2 (en) 2017-05-26 2019-05-21 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
CN111163834A (en) 2017-06-30 2020-05-15 隆佩瑟尔医疗公司 Device for preventing, reducing and/or treating cognitive impairment
US10195429B1 (en) 2017-08-02 2019-02-05 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
US10940308B2 (en) 2017-08-04 2021-03-09 Lungpacer Medical Inc. Systems and methods for trans-esophageal sympathetic ganglion recruitment
WO2020097331A1 (en) 2018-11-08 2020-05-14 Lungpacer Medical Inc. Stimulation systems and related user interfaces
EP3968932A4 (en) 2019-05-16 2023-01-18 Lungpacer Medical Inc. Systems and methods for sensing and stimulation
US11771900B2 (en) 2019-06-12 2023-10-03 Lungpacer Medical Inc. Circuitry for medical stimulation systems

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3757768A (en) * 1972-04-07 1973-09-11 Medical Evaluation Devices And Manipulable spring guide-catheter and tube for intravenous feeding
US4641649A (en) 1985-10-30 1987-02-10 Rca Corporation Method and apparatus for high frequency catheter ablation
EP0244818A2 (en) * 1986-05-08 1987-11-11 Terumo Kabushiki Kaisha Catheter
EP0536440A1 (en) * 1991-10-11 1993-04-14 Erbe Elektromedizin GmbH H.F. surgical instrument for cutting and coagulating
US5228442A (en) 1991-02-15 1993-07-20 Cardiac Pathways Corporation Method for mapping, ablation, and stimulation using an endocardial catheter
US5231995A (en) 1986-11-14 1993-08-03 Desai Jawahar M Method for catheter mapping and ablation
US5263493A (en) 1992-02-24 1993-11-23 Boaz Avitall Deflectable loop electrode array mapping and ablation catheter for cardiac chambers
US5281217A (en) 1992-04-13 1994-01-25 Ep Technologies, Inc. Steerable antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns
US5348545A (en) * 1990-08-21 1994-09-20 Advanced Cardiovascular Systems, Inc. Guiding catheter for the right coronary artery
US5425364A (en) 1991-02-15 1995-06-20 Cardiac Pathways Corporation Flexible strip assembly without feedthrough holes and device utilizing the same
US5456254A (en) 1991-02-15 1995-10-10 Cardiac Pathways Corp Flexible strip assembly having insulating layer with conductive pads exposed through insulating layer and device utilizing the same
US5476495A (en) 1993-03-16 1995-12-19 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5487385A (en) * 1993-12-03 1996-01-30 Avitall; Boaz Atrial mapping and ablation catheter system
WO1996016606A1 (en) * 1994-12-01 1996-06-06 Vidamed, Inc. Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence
WO1996022739A1 (en) * 1995-01-24 1996-08-01 Vidamed, Inc. Medical probe device with scope and proximal aspiraton openings and method for treatment of the prostate with same
US5575766A (en) 1993-11-03 1996-11-19 Daig Corporation Process for the nonsurgical mapping and treatment of atrial arrhythmia using catheters guided by shaped guiding introducers
WO1997006739A2 (en) * 1995-08-15 1997-02-27 Rita Medical Systems, Inc. Apparatus for ablation of a selected mass

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5154387A (en) * 1990-05-31 1992-10-13 Syncromed Corporation Method and apparatus for esophageal pacing
US5156151A (en) * 1991-02-15 1992-10-20 Cardiac Pathways Corporation Endocardial mapping and ablation system and catheter probe
US5348554A (en) * 1992-12-01 1994-09-20 Cardiac Pathways Corporation Catheter for RF ablation with cooled electrode
US5423772A (en) * 1993-08-13 1995-06-13 Daig Corporation Coronary sinus catheter
US5607462A (en) * 1993-09-24 1997-03-04 Cardiac Pathways Corporation Catheter assembly, catheter and multi-catheter introducer for use therewith
SE9401267D0 (en) * 1994-04-14 1994-04-14 Siemens Elema Ab The electrode device

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3757768A (en) * 1972-04-07 1973-09-11 Medical Evaluation Devices And Manipulable spring guide-catheter and tube for intravenous feeding
US4641649A (en) 1985-10-30 1987-02-10 Rca Corporation Method and apparatus for high frequency catheter ablation
EP0244818A2 (en) * 1986-05-08 1987-11-11 Terumo Kabushiki Kaisha Catheter
US5231995A (en) 1986-11-14 1993-08-03 Desai Jawahar M Method for catheter mapping and ablation
US5348545A (en) * 1990-08-21 1994-09-20 Advanced Cardiovascular Systems, Inc. Guiding catheter for the right coronary artery
US5228442A (en) 1991-02-15 1993-07-20 Cardiac Pathways Corporation Method for mapping, ablation, and stimulation using an endocardial catheter
US5425364A (en) 1991-02-15 1995-06-20 Cardiac Pathways Corporation Flexible strip assembly without feedthrough holes and device utilizing the same
US5456254A (en) 1991-02-15 1995-10-10 Cardiac Pathways Corp Flexible strip assembly having insulating layer with conductive pads exposed through insulating layer and device utilizing the same
EP0536440A1 (en) * 1991-10-11 1993-04-14 Erbe Elektromedizin GmbH H.F. surgical instrument for cutting and coagulating
US5263493A (en) 1992-02-24 1993-11-23 Boaz Avitall Deflectable loop electrode array mapping and ablation catheter for cardiac chambers
US5281217A (en) 1992-04-13 1994-01-25 Ep Technologies, Inc. Steerable antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns
US5476495A (en) 1993-03-16 1995-12-19 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5499981A (en) 1993-03-16 1996-03-19 Ep Technologies, Inc. Flexible interlaced multiple electrode assemblies
US5575766A (en) 1993-11-03 1996-11-19 Daig Corporation Process for the nonsurgical mapping and treatment of atrial arrhythmia using catheters guided by shaped guiding introducers
US5487385A (en) * 1993-12-03 1996-01-30 Avitall; Boaz Atrial mapping and ablation catheter system
WO1996016606A1 (en) * 1994-12-01 1996-06-06 Vidamed, Inc. Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence
WO1996022739A1 (en) * 1995-01-24 1996-08-01 Vidamed, Inc. Medical probe device with scope and proximal aspiraton openings and method for treatment of the prostate with same
WO1997006739A2 (en) * 1995-08-15 1997-02-27 Rita Medical Systems, Inc. Apparatus for ablation of a selected mass

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8864758B2 (en) 2003-01-21 2014-10-21 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter design that facilitates positioning at tissue to be diagnosed or treated
EP1916956A2 (en) * 2005-08-22 2008-05-07 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation
EP1916956A4 (en) * 2005-08-22 2010-12-01 St Jude Medical Atrial Fibrill Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation
WO2017178077A1 (en) * 2016-04-15 2017-10-19 Glenn Van Langenhove Improved method and device for ablation
WO2018193283A1 (en) 2017-04-18 2018-10-25 Glenn Van Langenhove Improved device for ablation

Also Published As

Publication number Publication date
US5785706A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
US5785706A (en) Nonsurgical mapping and treatment of cardiac arrhythmia using a catheter contained within a guiding introducer containing openings
US6090084A (en) Shaped guiding introducers for use with a catheter for the treatment of atrial arrhythmia
EP0670168B1 (en) Guiding introducer for the nonsurgical mapping and treatment of atrial arrhythmia using catheters guided by the shaped guiding introducers
US5564440A (en) Method for mopping and/or ablation of anomalous conduction pathways
US5628316A (en) Guiding introducer system for use in the right atrium
US5902289A (en) Precurved guiding introducer system for treatment of atrial arrhythmia
US5715818A (en) Method of using a guiding introducer for left atrium
US7248913B2 (en) Guiding introducer system for use in medical procedures in the left ventricle
US5810730A (en) Guiding introducer for right atrium
US6540755B2 (en) Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach
US6203531B1 (en) Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach
US5947938A (en) Process for the nonsurgical mapping and/or treatment of ectopic atrial tachycardia using a guiding introducer
CA2150784A1 (en) Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach
JP3185648B2 (en) Lead introducer for treatment of atrial flutter
WO1999025411A1 (en) Catheter guiding introducers for use in pediatric hearts
JP2004275786A (en) Non-surgical mapping for atrial arrhythmia and shaped guiding introducer for medical treatment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998523909

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase